budesonide (Budenofalk) Abbreviated
Following an abbreviated submission:
budesonide 9mg gastro-resistant granules (Budenofalk®) is accepted for use within NHS Scotland.
Indication under review: induction of remission in patients with active collagenous colitis.
Budesonide gastro-resistant granules provides a once daily alternative to budesonide gastro-resistant 3mg capsules (which are given three times daily) at no additional cost. The granules may have advantages for patients who have difficulty swallowing.
|Drug Name:||budesonide (Budenofalk) Abbreviated|
|SMC Drug ID:||831/12|
|Manufacturer:||Dr Falk Pharma UK|
|Indication:||Induction of remission in patients with active collagenous colitis.|
|Sub Category:||1.5 Chronic bowel disorders|
|Submission Type:||Abbreviated Submission|
|Date Advice Published:||14 January 2013|